Diginex’s New Compliance Platform Faces Market Skepticism as Founder Bets Big on June 12 Deal

Diginex's new compliance platform fails to lift stock as investors await June 12 deadline for transformative Resulticks acquisition; insider Pelham's $25.4M bet down 80%.

Diginex rolled out a fresh supply-chain compliance platform on Thursday, yet the stock promptly shed more than 6%, sliding to $1.03. The “Risk-to-Remedy” product, built around three integrated modules — LUMEN for risk analysis, APPRISE for worker engagement, and the acquired Remedy Project for grievance handling — aims to move ESG reporting from backward-looking disclosure to proactive compliance. The market’s response, however, suggests investors are focused on a different timeline.

The 30-day chart tells a grim story: a 43% decline that has driven the relative strength index to 30.2, a technically oversold reading. Annualized volatility hovers near 156%, underscoring the speculative nature of the equity. The product launch did nothing to reverse the selling pressure, and the share price remains stuck at levels that had already telegraphed the weakness.

Against that backdrop, Chairman and founder Miles Pelham has quietly injected $25.4 million of his own capital into the company since the IPO, at an average price of $5.69 per share. Diginex presents the sum as a long-term conviction signal, but the current market value of those shares has shrunk by more than 80% from the entry price. Pelham’s vote of confidence is real in dollar terms, yet it has not arrested the slide.

The reason for the market’s impatience likely lies in the stalled Resulticks acquisition. The deadline to close that deal has already been pushed back once — from May 29 to June 12, 2026 — with the company citing outstanding closing conditions. Resulticks is expected to bring “real-time decisioning” capabilities that would transform Diginex from a narrow RegTech provider into a broader data and customer-intelligence platform, targeting $150 million in annual revenue and up to $50 million in EBITDA. But those figures remain contingent on the deal actually closing, and the SEC filing explicitly states no guarantee of completion.

Diginex is therefore juggling two competing narratives. On one side, it is expanding organically with the new supply-chain tool. On the other, it is trying to pull off a transformative M&A transaction that would pull together sustainability data, AI analytics, and customer engagement. The stock’s 43% monthly plunge suggests investors are pricing in considerable risk that the June 12 deadline slips again — or fails entirely. Until then, the new platform and Pelham’s multimillion-dollar bet will do little more than fill the waiting room.